Harmony Biosciences Holdings, Inc. (HRMY)
40.51
+0.92
(+2.32%)
USD |
NASDAQ |
Dec 12, 16:00
40.50
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Shareholders Equity (Quarterly): 835.12M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| Halozyme Therapeutics, Inc. | 503.92M |
| Capricor Therapeutics, Inc. | 83.87M |
| Nurix Therapeutics, Inc. | 372.25M |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.208B |
| Total Liabilities (Quarterly) | 373.10M |
| Debt to Equity Ratio | 0.2719 |
| Current Ratio | 3.755 |
| Net Debt Paydown Yield | -0.10% |